Dormant
CLFD · Clearfield, Inc.
Last analysed ·
Resolved Graded and closed 2026-06-09 at low conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-09-20 and is not part of the scored record.
Current thesis
The May earnings-miss squeeze has fully round-tripped to a dead tape in the mid-$30s, below the ~$36 gap base, with the retail-sentiment narrative spent. The sole live driver is the 2026-08-05 fiscal-Q3 print — guided to a sharp sequential ramp ($42-46M off a $34.4M trough) the tape refuses to pay for ahead of time, into a name with steady insider selling and BEAD revenue slipping to FY2027.
Kill line
A weekly close below $32 confirms the full round-trip of the May squeeze and opens the high-$20s toward the $23.76 annual low; a fiscal-Q3 net-sales print under the $42M guide floor on 2026-08-05, book-to-bill below 1.0, or BEAD deferred past FY2027 hardens the break.
Pick status
Invalidated resolved published kill line fired How this is scored →Latest analysis and events for CLFD —
As of 20 September 2026, the latest FrontierPicks analysis for Clearfield, Inc. (CLFD): The May earnings-miss squeeze has fully round-tripped to a dead tape in the mid-$30s, below the ~$36 gap base, with the retail-sentiment narrative spent. The sole live driver is the 2026-08-05 fiscal-Q3 print — guided to a sharp sequential ramp ($42-46M off a $34.4M trough) the tape refuses to pay for ahead of time, into a name with steady insider selling and BEAD revenue slipping to FY2027.
Kill line: A weekly close below $32 confirms the full round-trip of the May squeeze and opens the high-$20s toward the $23.76 annual low; a fiscal-Q3 net-sales print under the $42M guide floor on 2026-08-05, book-to-bill below 1.0, or BEAD deferred past FY2027 hardens the break.
Next dated event on file: — catalyst in 10d.
Current Thesis
Clearfield’s recovery thesis depends on its announced hyperscale order becoming revenue and broadband orders rebuilding; the next annual results test that case, while a weekly close below $28.65 would invalidate the price recovery. The $22 million order announced on 2026-08-05 provides a concrete demand source, but management scheduled initial shipments only for early fiscal 2027. Clearfield’s fiscal-Q3 release supports an order-conversion thesis, not an established recurring data-center business.
The measured change since the 2026-09-06 assessment is price improvement: the adjusted close reached $30.16 on 2026-09-18, versus the documented $28.65 close on 2026-09-04. That remains below the prior research threshold of $32. For the May retail-squeeze story, the narrative is dead — the 2026-09-18 close remains beneath the level whose breach was documented on 2026-09-06; this classification is an inference about that failed structure, not evidence that operating recovery is impossible.
The replacement case is a low-conviction recovery in a fiber-infrastructure supplier. Its defined price outcome is a weekly close above $32 before a weekly close below $28.65, assessed through the next annual results. The earlier thesis already failed its $32 condition; this separate recovery test does not reverse that outcome.
Bullish and bearish views on Clearfield, Inc.
The model's bull view on Clearfield, Inc. (CLFD), in brief: A disclosed hyperscale demand source. Clearfield announced a $22 million order on 2026-08-05, after its June quarter ended. Management’s early-fiscal-2027 shipment expectation makes conversion into reported revenue the relevant test. Company release. This establishes reported… The bear view: Backlog deterioration preceded the award. Both cases follow in full.
Bull Case
- A disclosed hyperscale demand source. Clearfield announced a $22 million order on 2026-08-05, after its June quarter ended. Management’s early-fiscal-2027 shipment expectation makes conversion into reported revenue the relevant test. Company release.
- This establishes reported growth for that quarter; it does not establish a sustained recovery. Financial results.
- Distribution reach expanded in September. Clearfield announced its WAV distribution agreement on 2026-09-02. The announcement disclosed no minimum volumes, so the channel cannot yet support a quantified revenue forecast. Company news record.
Bear Case
- Backlog deterioration preceded the award. June 30, 2026 backlog was $21.0 million, down 34% sequentially, after removal of a $4.6 million order. The subsequently announced hyperscale award therefore needs to be distinguished from recovery in the existing customer base. Fiscal-Q3 release.
- Guidance still describes softer sales. On 2026-08-05, management guided fiscal-Q4 revenue to $38–42 million and reduced fiscal-2026 revenue guidance to $151–155 million. A fiscal-Q4 result below $38 million would contradict the proposed stabilization. Company outlook.
- Margins weakened during revenue growth. Fiscal-Q3 gross margin was 31.8%, versus 35.3% a year earlier, as reported on 2026-08-05. Higher sales alone did not establish improving profitability. Financial results.
Setup & Price Structure
The 2026-09-18 adjusted close was $30.16; the shares were down 24.6% over three months and 41.2% below their $51.26 trailing-year high. The 14-day relative strength index was 53.5 on that date. These observations describe a recent improvement inside a larger decline; they do not demonstrate expanding participation.
The $28.65 reference is the documented 2026-09-04 market close, not a verified intraday low or a proven support shelf. The supplied observations are too sparse to establish a base. The $32 level remains the prior research threshold whose recovery would satisfy the price test described above.
The 2026-07-01 chief executive Form 4 documented selling under a Rule 10b5-1 plan adopted on 2025-12-15. That establishes scheduled insider supply, not a discretionary bearish forecast. No current short-interest, retail-flow, trading-volume or moving-average series is available in the dated evidence, so a renewed squeeze or crowding claim is unsupported.
Catalyst Calendar (next 30 days)
Clearfield’s investor calendar listed no upcoming events when checked on 2026-09-20. The dates below distinguish accounting milestones from public disclosures. Company calendar.
- 2026-09-30 — Fiscal year closes. This ends the quarter covered by management’s 2026-08-05 revenue guidance. It is not an announced results-release date.
- 2026-10-01 — Fiscal 2027 begins. This opens the fiscal year containing management’s early-year shipment window for the hyperscale order. No exact shipment date was announced on 2026-08-05.
- ~2026-11-24, est. Annual results window. This remains an unconfirmed planning date from the prior assessment; the previous annual release occurred on 2025-11-25. The forthcoming report matters because it can establish September revenue, closing backlog and shipment progress. Prior annual release.
What Would Change Our Mind
Loss of the September recovery would occur with a weekly close below $28.65, the 2026-09-04 reference close. Failure to reclaim $32 on a weekly close by the next annual results would leave the stated price outcome unmet even without that downside breach.
Operating evidence would strengthen if September backlog exceeds the June 30 reading of $21.0 million and management confirms shipments against the disclosed hyperscale order. Backlog improvement attributable solely to that previously announced award would not establish broader customer recovery. Fiscal-Q4 sales below the $38 million guidance floor, or management withdrawing its early-fiscal-2027 shipment expectation, would contradict the operating thesis.
Correlation Notes
This is a single-name recovery case. The 2026-08-05 order disclosure establishes exposure to a hyperscale project, but it does not establish artificial-intelligence revenue or measured correlation with semiconductor shares. No dated peer-return series supports a statistical correlation claim.
The relevant operating connection remains customer spending on fiber infrastructure: Clearfield’s 2026-08-05 release identifies broadband capital spending and government-funding timing as demand risks. A sector rally alone would not settle whether those customers are placing new orders.
Notes
- Fiscal year ends September 30. The FY2025 Q4 call was 2025-11-25 after a 2025-11-04 notice, so any November 2026 date is an estimate until announced.
- Data-center exposure is one $22M order disclosed 2026-08-05, guided to ship from early fiscal 2027. No recurring data-center revenue has been recognized.
- Guidance is stated in GAAP terms: FY2026 EPS of $0.14-0.21 and fiscal-Q4 EPS of $0.00-0.07.
- The 2026-09-02 WAV distribution announcement disclosed no contract terms, minimum volumes or duration.
Related · shared themes
ALAB
Astera Labs, Inc.
Q2 (2026-08-04) answered the July margin question: GM 73.7% vs ~73% guide, and Q3 guided $540–560M vs $416.5M consensus (~40% QoQ) with Scorpio X switches in volume production a quarter early. Price has not confirmed — the 2026-08-14 close of $321.61 is ~11% below the post-print level and 33.4% under the $483.02 52-week high.
CRDO
Credo Technology Group Holding Ltd
Interconnect/AEC royalty narrative still accelerating, not fading — new 52-week highs on late-June initiations (Evercore $325, Stifel $350, BofA $340) plus the early-July AI-buildout rally. But it's now mainstream and widely held, entering a ~6-week catalyst void until the late-Aug Q1 FY27 print with macro tightening; continuation intact, though chasing all-time highs here is lower-edge than a pullback to support.
KEYS
Keysight Technologies, Inc.
Analyst-migration re-rate's second leg (Morgan Stanley to Overweight, PT $400, 2026-07-13) has stalled — silent tape near 28x forward, empty calendar until the ~2026-08-19 Q3 FY26 print. The $290–300 breakout-shelf entry hasn't come; current levels buy the tail. Theme accelerating, the KEYS expression maturing.
KOPN
Kopin Corporation
Kopin Corporation's defense orders and optical-interconnect pivot support a recovery case toward the $6.39 market high recorded as of 2026-09-18. The forecast succeeds if that high is reached by the next quarterly report, estimated for 2026-11-10, before a weekly close below $4.00 invalidates it.